'The HemOnc Pulse' Live: What Research is Needed in CML?

'The HemOnc Pulse' Live: What Research is Needed in CML?Подробнее

The HemOnc Pulse Live at ASH 2022: Elias Jabbour, MD, on Immunotherapy Advances in ALLПодробнее

The HemOnc Pulse Live at ASH: Tycel Phillips, MD, on the TRIANGLE Study, Frontline Therapy in MCLПодробнее

Introducing The HemOnc Pulse hosted by Chadi Nabhan, MD, MBA, FACPПодробнее

Unmet needs in CMLПодробнее

The HemOnc Pulse Live at ASH: Jeffrey Lancet, MDПодробнее

Live In Chicago, It's "The HemOnc Pulse"! #HOPLive24Подробнее

'The HemOnc Pulse' Live: Summarizing the Unmet Needs in CLLПодробнее

COMPLETE Hematology/Oncology Review for the USMLE (130 Questions)Подробнее

The HemOnc Pulse Live at ASH: Naval Daver, MD, on Treating AML in Older Adults, Novel TherapiesПодробнее

Lessons in Blood Cancer: How Far We Have Come CMLПодробнее

Challenging CML scenariosПодробнее

"The HemOnc Pulse" Live: Caron Jacobson, MD, Talks Unanswered Questions in CAR-T #HOPLive24Подробнее

Sanam Loghavi, MD: 'The HemOnc Pulse' Live Sheds a Spotlight on Hematopathology #HOPLive24Подробнее

The HemOnc Pulse Live at ASH: Sagar Lonial, MD, FACP, on Role of Transplant, MRD in MyelomaПодробнее

Phase I study of olverembatinib in patients with R/R CML & Ph+ ALLПодробнее

The importance of improving treatment-free remission in patients with CMLПодробнее

The molecular complexity of CMLПодробнее

Phase I study of asciminib in patients with CP-CML carrying the T315I mutationПодробнее

Clinical trial updates in CMLПодробнее